BCP
ONC

BSN Capital Partners’s BeOne Medicines Ltd ONC Stock Holding History

BSN Capital Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-43,400
Closed -$11.8M – 20
2021
Q4 		$11.8M Buy
+43,400
New +$14.7M 0.75% 19

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

BSN Capital Partners's ONC Position: Q1 2022 in Review

BSN Capital Partners sold out of BeOne Medicines Ltd (ONC) in Q1 2022, closing a stake of 43,400 shares — an estimated $11.8M sold.

BSN Capital Partners first reported a position in ONC in Q4 2021 and held it in 1 quarter. The position peaked at $11.8M in Q4 2021. 238 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • BSN Capital Partners reported no remaining BeOne Medicines Ltd position as of Q1 2022 after selling out during the quarter.
  • BSN Capital Partners sold 43,400 BeOne Medicines Ltd shares in Q1 2022, an estimated $11.8M.
  • BSN Capital Partners first reported a position in BeOne Medicines Ltd in Q4 2021 and held it in 1 quarter.
  • BSN Capital Partners's BeOne Medicines Ltd position peaked at $11.8M in Q4 2021.
  • 238 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on BSN Capital Partners's 13F filing for Q1 2022.